A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...

Aurobindo Pharma shares fell nearly 5% to ₹1,039 amid reports it may acquire Zentiva for $5-5.5 billion. This would be the ...

Aurobindo Pharma shares fell 4.67 per cent to hit a high of Rs 1,039.30 on BSE, commanding a market capitalisation of just ...

Reports suggested it has emerged as the frontrunner to acquire Prague-based Zentiva for $5 to $5.5 billion. If completed, this would be the largest-ever acquisition by an Indian pharma company.

DS 6157: Daiichi Sankyo Company DS-6157 is a potential first-in-class GPR20 targeting ADC and the fifth DXd ADC in the ...

Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung ...

On an earnings call, CSL CEO Paul McKenzie described weakness in the U.S. market for seasonal flu vaccines as “disappointing” ...

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Tokyo stocks reached all-time highs for a second consecutive day and for the fourth time in six trading days, and then ...